From the Departments of Radiology (L.B.M., M.B.B., S.E.R.) and Radiation Oncology (G.C.S.), Mercy Catholic Medical Center, 1500 Lansdowne Ave, Darby, PA 19023-1200; and Department of Plastic and Reconstructive Surgery, St Mary's Medical Center, Langhorne, PA (J.G.F.).
Radiographics. 2023 Mar;43(3):e220086. doi: 10.1148/rg.220086.
Radiation therapy represents a pillar in the current management of breast cancer. Historically, postmastectomy radiation therapy (PMRT) has been administered only in patients with locally advanced disease and a poor prognosis. These included patients with large primary tumors at diagnosis and/or more than three metastatic axillary lymph nodes. However, during the past few decades, several factors have prompted a shift in perspective, and recommendations for PMRT have become more fluid. Guidelines for PMRT in the United States are outlined by the National Comprehensive Cancer Network and the American Society for Radiation Oncology. Because evidence to support performing PMRT is frequently discordant, the decision to offer radiation therapy often requires team discussion. These discussions are usually held in multidisciplinary tumor board meetings in which radiologists play a pivotal role by providing critical information such as the location and extent of disease. Breast reconstruction after mastectomy is optional and is safe in cases in which the patient's clinical status allows it. The preferred method in the setting of PMRT is autologous reconstruction. If this is not possible, then a two-step implant-based reconstruction is recommended. Radiation therapy does involve a risk of toxicity. Complications can be seen in acute and chronic settings and range from fluid collections and fractures to radiation-induced sarcomas. Radiologists have a key role in detecting these and other clinically relevant findings and should be prepared to recognize, interpret, and address them. RSNA, 2023 Quiz questions for this article are available in the supplemental material.
放射治疗是当前乳腺癌治疗的主要手段之一。从历史上看,仅在局部晚期疾病和预后不良的患者中进行乳房切除术后放射治疗(PMRT)。这些患者包括在诊断时具有较大原发肿瘤和/或超过三个转移性腋窝淋巴结的患者。然而,在过去几十年中,有几个因素促使人们的观点发生转变,对 PMRT 的建议变得更加灵活。美国的 PMRT 指南由国家综合癌症网络和美国放射肿瘤学会制定。由于支持进行 PMRT 的证据经常存在不一致,因此提供放射治疗的决定通常需要团队讨论。这些讨论通常在多学科肿瘤委员会会议上进行,放射科医生通过提供关键信息(例如疾病的位置和范围)发挥关键作用。乳房切除术后的乳房重建是可选的,如果患者的临床状况允许,重建是安全的。PMRT 情况下的首选方法是自体重建。如果这不可能,则推荐两步式基于植入物的重建。放射治疗确实存在毒性风险。并发症可在急性和慢性环境中出现,范围从积液和骨折到放射诱导肉瘤。放射科医生在检测这些和其他临床相关发现方面发挥着关键作用,应准备好识别、解释和处理这些发现。RSNA,2023 本文的测验问题可在补充材料中找到。